So-Young Lee

Title: So-Young Lee: Innovator in Cancer Diagnosis and Treatment

Introduction

So-Young Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of cancer diagnosis and treatment, holding a total of 3 patents. His innovative work focuses on developing novel compounds that can effectively target and treat prostate cancer.

Latest Patents

One of So-Young Lee's latest patents is titled "GRP-R agonistic 177-lutetium-labeled bombesin derivatives for diagnosis and treatment of prostate cancer." This patent provides a novel compound capable of diagnosing and treating prostate cancer by labeling a radioisotope on bombesin derivatives. These derivatives selectively target materials that are over-expressed in tumor cells, thereby developing effective diagnostic and treatment methods for diseases associated with prostate cancer. Another significant patent involves "Novel NSchelator-folate derivatives, a preparation method thereof, and a composition for diagnosis and treatment of tumor including the same as an active ingredient." This invention allows for easy introduction into cells using receptor binding to tumor-expressing α-folate receptors. The folate derivatives, labeled with radioisotopes such as technetium or rhenium, can be used for tumor imaging and irradiation, making them valuable for labeling various radiopharmaceuticals.

Career Highlights

So-Young Lee has worked with notable institutions, including the Korea Atomic Energy Research Institute and Moghu Research Center Ltd. His work at these organizations has contributed to advancements in cancer research and treatment methodologies.

Collaborations

So-Young Lee has collaborated with several professionals in his field, including Young-Don Hong and Sun-Ju Choi. These collaborations have further enhanced his research and development efforts in cancer diagnostics and therapeutics.

Conclusion

So-Young Lee's innovative contributions to cancer diagnosis and treatment demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of the complexities of cancer and the potential for targeted therapies. His work continues to inspire future innovations in the field.